Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2001-11-21
pubmed:abstractText
Accurate diagnosis of mosquito allergy has been precluded by the difficulty of obtaining salivary allergens. In this study, we expressed, purified, characterized and investigated the clinical relevance of a recombinant Aedes aegypti salivary allergen, rAed a 1. Two cDNA segments were ligated together to form the full-length Aed a 1 gene. rAed a 1 was expressed using a baculovirus/insect cell system, and purified using a combination of anion-exchange and gel-filtration chromatography. The purified rAed a 1 bound to human IgE, as detected by ELISA, ELISA inhibition tests and immunoblot analyses. Epicutaneous tests with rAed a 1 and a commercial whole-body AE: aegypti extract, and AE: aegypti bite tests were performed in 48 subjects. Nine of 31 (29%) of the subjects with positive immediate bite tests also had a positive rAed a 1 immediate skin reaction and 32% had an positive immediate test to the commercial extract. Six of 33 (18%) of the subjects with positive delayed bite tests also had a positive rAed a 1 delayed skin reaction and 6% had a positive delayed test to the commercial extract. Furthermore, rAed a 1-induced flare sizes significantly correlated with mosquito bite-induced flare sizes. None of the subjects with negative bite tests had a positive skin test to rAed a 1 or to commercial extract. We conclude that the rAed a 1 has identical antigenicity and biological activity to native Aed a 1, can be used in the in vitro and in vivo diagnosis of mosquito allergy, and is more sensitive than mosquito whole-body extract for detecting delayed skin reactions.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0953-8178
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1445-52
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:11717185-Aedes, pubmed-meshheading:11717185-Allergens, pubmed-meshheading:11717185-Animals, pubmed-meshheading:11717185-Antigens, Plant, pubmed-meshheading:11717185-Baculoviridae, pubmed-meshheading:11717185-Binding, Competitive, pubmed-meshheading:11717185-Binding Sites, Antibody, pubmed-meshheading:11717185-Bites and Stings, pubmed-meshheading:11717185-Cells, Cultured, pubmed-meshheading:11717185-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:11717185-Humans, pubmed-meshheading:11717185-Hypersensitivity, Delayed, pubmed-meshheading:11717185-Hypersensitivity, Immediate, pubmed-meshheading:11717185-Insect Proteins, pubmed-meshheading:11717185-Isoelectric Point, pubmed-meshheading:11717185-Molecular Weight, pubmed-meshheading:11717185-Recombinant Proteins, pubmed-meshheading:11717185-Salivary Proteins and Peptides, pubmed-meshheading:11717185-Skin Tests, pubmed-meshheading:11717185-Spodoptera, pubmed-meshheading:11717185-Time Factors
pubmed:year
2001
pubmed:articleTitle
Expression, purification, characterization and clinical relevance of rAed a 1--a 68-kDa recombinant mosquito Aedes aegypti salivary allergen.
pubmed:affiliation
Department of Pediatrics and Child Health, and Department of Immunology, University of Manitoba, Winnipeg, Manitoba R3E 3P5, Canada. zpeng@ms.umanitoba.ca
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't